基础医学与临床 ›› 2012, Vol. 32 ›› Issue (2): 154-157.

• 研究论文 • 上一篇    下一篇

43例中国眼部恶性黑色素瘤cKit和BRAF基因突变分析

孔燕,梁龙,斯璐,代杰,俎明,张虔男,郭军   

  1. 北京肿瘤医院
  • 收稿日期:2011-12-19 修回日期:2011-12-21 出版日期:2012-02-05 发布日期:2012-01-12
  • 通讯作者: 郭军 E-mail:guoj307@126.com
  • 基金资助:
    中国人恶性黑色素瘤的基因变异与靶向治疗的选择;中国黑色素瘤个体化靶向治疗模式的探索

Analysis cKit and BRAF mutations in 43 Chinese patients with ocular melanomas

  • Received:2011-12-19 Revised:2011-12-21 Online:2012-02-05 Published:2012-01-12

摘要: 目的 分析中国眼部恶性黑色素瘤中cKit和BRAF基因突变情况。方法 收集43例中国眼部恶性黑色素瘤患者组织标本(脉络膜恶性黑色素瘤30例,结膜恶性黑色素瘤13例), 采用巢式PCR扩增和基因测序的方法检测cKit基因第9,11,13,17,18外显子以及BRAF基因第15外显子突变情况。结果cKit基因在脉络膜恶性黑色素瘤患者中突变率达16.7%(5/30),而在结膜恶性黑色素瘤中突变率仅为7.7% (1/13);在结膜恶性黑色素瘤中检测到1例BRAF基因突变(1/13),在脉络膜恶性黑色素瘤中未检测到BRAF基因突变。结论 本研究首次报道cKit基因在中国脉络膜恶性黑色素瘤患者中突变率较高,提示以cKit为靶标的靶向药物未来有可能为中国眼部恶性黑色素瘤患者,尤其是脉络膜恶性黑色素瘤患者带来新的希望。

关键词: 眼部恶性黑色素瘤, cKit, BRAF, 基因突变, 靶向治疗

Abstract: Objective This study was designed to investigate the frequency of cKit/BRAF gene mutations in Chinese patients with ocular melanoma. Methods Forty-three ocular melanomas (30 choroidal melanomas ,13 conjunctival melanomas) were analyzed for mutations in exons 9,11,13,17,18 of cKit and in exon 15 of BRAF in genomic DNA by PCR amplification and sanger sequencing. Results In the choroidal and conjunctival melanoma subtypes, the frequency of cKit mutations was 16.7% (5/30) and (1/13), respectively. A single conjunctival melanoma harbored BRAF mutation and choroidal mealanoma lack BRAF mutation. Conclusion For the first time, this study suggests the frequency of cKit mutations was 16.7% in Chinese patients with choroidal melanomas and the cKit inhibitor might play their roles in Chinese patients with choroidal melanomas.

Key words: ocular melanoma , cKit , BRAF , gene mutation , target-therapy

中图分类号: